429 related articles for article (PubMed ID: 24591732)
1. An induced pluripotent stem cell model of hypoplastic left heart syndrome (HLHS) reveals multiple expression and functional differences in HLHS-derived cardiac myocytes.
Jiang Y; Habibollah S; Tilgner K; Collin J; Barta T; Al-Aama JY; Tesarov L; Hussain R; Trafford AW; Kirkwood G; Sernagor E; Eleftheriou CG; Przyborski S; Stojković M; Lako M; Keavney B; Armstrong L
Stem Cells Transl Med; 2014 Apr; 3(4):416-23. PubMed ID: 24591732
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cell modelling of HLHS underlines the contribution of dysfunctional NOTCH signalling to impaired cardiogenesis.
Yang C; Xu Y; Yu M; Lee D; Alharti S; Hellen N; Ahmad Shaik N; Banaganapalli B; Sheikh Ali Mohamoud H; Elango R; Przyborski S; Tenin G; Williams S; O'Sullivan J; Al-Radi OO; Atta J; Harding SE; Keavney B; Lako M; Armstrong L
Hum Mol Genet; 2017 Aug; 26(16):3031-3045. PubMed ID: 28521042
[TBL] [Abstract][Full Text] [Related]
3. Directed differentiation of patient-specific induced pluripotent stem cells identifies the transcriptional repression and epigenetic modification of NKX2-5, HAND1, and NOTCH1 in hypoplastic left heart syndrome.
Kobayashi J; Yoshida M; Tarui S; Hirata M; Nagai Y; Kasahara S; Naruse K; Ito H; Sano S; Oh H
PLoS One; 2014; 9(7):e102796. PubMed ID: 25050861
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathways and Animal Models of Hypoplastic Left Heart Syndrome.
Yagi H; Xu X; Gabriel GC; Lo C
Adv Exp Med Biol; 2024; 1441():947-961. PubMed ID: 38884763
[TBL] [Abstract][Full Text] [Related]
5. NOTCH1-Dependent Nitric Oxide Signaling Deficiency in Hypoplastic Left Heart Syndrome Revealed Through Patient-Specific Phenotypes Detected in Bioengineered Cardiogenesis.
Hrstka SC; Li X; Nelson TJ;
Stem Cells; 2017 Apr; 35(4):1106-1119. PubMed ID: 28142228
[TBL] [Abstract][Full Text] [Related]
6. Establishment of NCHi009-A, an iPSC line from a patient with hypoplastic left heart syndrome (HLHS) carrying a heterozygous NOTCH1 mutation.
Adhicary S; Ye S; Lin H; Texter K; Garg V; Zhao MT
Stem Cell Res; 2023 Feb; 66():103013. PubMed ID: 36599283
[TBL] [Abstract][Full Text] [Related]
7. Contractility of Induced Pluripotent Stem Cell-Cardiomyocytes With an
Kim MS; Fleres B; Lovett J; Anfinson M; Samudrala SSK; Kelly LJ; Teigen LE; Cavanaugh M; Marquez M; Geurts AM; Lough JW; Mitchell ME; Fitts RH; Tomita-Mitchell A
Front Cell Dev Biol; 2020; 8():440. PubMed ID: 32656206
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Non-Coding RNAs in Exosomes and Functional Efficacy of Human Embryonic Stem Cell- versus Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Lee WH; Chen WY; Shao NY; Xiao D; Qin X; Baker N; Bae HR; Wei TT; Wang Y; Shukla P; Wu H; Kodo K; Ong SG; Wu JC
Stem Cells; 2017 Oct; 35(10):2138-2149. PubMed ID: 28710827
[TBL] [Abstract][Full Text] [Related]
9. Hypoplastic left heart syndrome myocytes are differentiated but possess a unique phenotype.
Bohlmeyer TJ; Helmke S; Ge S; Lynch J; Brodsky G; Sederberg JH; Robertson AD; Minobe W; Bristow MR; Perryman MB
Cardiovasc Pathol; 2003; 12(1):23-31. PubMed ID: 12598014
[TBL] [Abstract][Full Text] [Related]
10. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
[TBL] [Abstract][Full Text] [Related]
11. Fetal reprogramming and senescence in hypoplastic left heart syndrome and in human pluripotent stem cells during cardiac differentiation.
Gaber N; Gagliardi M; Patel P; Kinnear C; Zhang C; Chitayat D; Shannon P; Jaeggi E; Tabori U; Keller G; Mital S
Am J Pathol; 2013 Sep; 183(3):720-34. PubMed ID: 23871585
[TBL] [Abstract][Full Text] [Related]
12. Re-evaluation of hypoplastic left heart syndrome from a developmental and morphological perspective.
Crucean A; Alqahtani A; Barron DJ; Brawn WJ; Richardson RV; O'Sullivan J; Anderson RH; Henderson DJ; Chaudhry B
Orphanet J Rare Dis; 2017 Aug; 12(1):138. PubMed ID: 28793912
[TBL] [Abstract][Full Text] [Related]
13. Characterization of an iPSC line NCHi006-A from a patient with hypoplastic left heart syndrome (HLHS).
Alonzo M; Contreras J; Ye S; Lin H; Hernandez-Rosario L; McBride KL; Texter K; Garg V; Zhao MT
Stem Cell Res; 2022 Oct; 64():102892. PubMed ID: 35987121
[TBL] [Abstract][Full Text] [Related]
14. Catecholamine-Dependent β-Adrenergic Signaling in a Pluripotent Stem Cell Model of Takotsubo Cardiomyopathy.
Borchert T; Hübscher D; Guessoum CI; Lam TD; Ghadri JR; Schellinger IN; Tiburcy M; Liaw NY; Li Y; Haas J; Sossalla S; Huber MA; Cyganek L; Jacobshagen C; Dressel R; Raaz U; Nikolaev VO; Guan K; Thiele H; Meder B; Wollnik B; Zimmermann WH; Lüscher TF; Hasenfuss G; Templin C; Streckfuss-Bömeke K
J Am Coll Cardiol; 2017 Aug; 70(8):975-991. PubMed ID: 28818208
[TBL] [Abstract][Full Text] [Related]
15. Impact of MYH6 variants in hypoplastic left heart syndrome.
Tomita-Mitchell A; Stamm KD; Mahnke DK; Kim MS; Hidestrand PM; Liang HL; Goetsch MA; Hidestrand M; Simpson P; Pelech AN; Tweddell JS; Benson DW; Lough JW; Mitchell ME
Physiol Genomics; 2016 Dec; 48(12):912-921. PubMed ID: 27789736
[TBL] [Abstract][Full Text] [Related]
16. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
17. Hypoplastic left heart syndrome: From bedside to bench and back.
Saraf A; Book WM; Nelson TJ; Xu C
J Mol Cell Cardiol; 2019 Oct; 135():109-118. PubMed ID: 31419439
[TBL] [Abstract][Full Text] [Related]
18. Novel Protein-Protein Interactions Highlighting the Crosstalk between Hypoplastic Left Heart Syndrome, Ciliopathies and Neurodevelopmental Delays.
Karunakaran KB; Gabriel GC; Balakrishnan N; Lo CW; Ganapathiraju MK
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456433
[TBL] [Abstract][Full Text] [Related]
19. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.
Preininger MK; Jha R; Maxwell JT; Wu Q; Singh M; Wang B; Dalal A; Mceachin ZT; Rossoll W; Hales CM; Fischbach PS; Wagner MB; Xu C
Dis Model Mech; 2016 Sep; 9(9):927-39. PubMed ID: 27491078
[TBL] [Abstract][Full Text] [Related]
20. Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.
Streckfuss-Bömeke K; Tiburcy M; Fomin A; Luo X; Li W; Fischer C; Özcelik C; Perrot A; Sossalla S; Haas J; Vidal RO; Rebs S; Khadjeh S; Meder B; Bonn S; Linke WA; Zimmermann WH; Hasenfuss G; Guan K
J Mol Cell Cardiol; 2017 Dec; 113():9-21. PubMed ID: 28941705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
